RAPIBLYK
Active substance: landiolol
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · LANDIOLOL HYDROCHLORIDE 280 mg/1
United StatesActive
Marketing holder: AOP Orphan Pharmaceuticals GmbH
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- LANDIOLOL HYDROCHLORIDE · 280 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208f-518d-7ae6-81e6-a2413be393c8;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 84381-110
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 84381-110 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 84381-110 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 84381-110 · Verified 2026-10-09 · open in source